
    
      This is a 49 weeks prospective, observational cohort study. Wuhan initiated a project to
      improve the LAI treatment in schizophrenia patient with violence risk. This observational
      study will build the cohort of schizophrenia patient with violence risk and treated with LAI
      paliperidone palmitate. The effect of long-acting antipsychotic, paliperidone palmitate, will
      be observed on prevention of recurrence and symptom control in these patients. safety
      information and laboratory tests result will also be collected. This study can be extended
      according to the implementation of the project and extended follow-up time.
    
  